His primary scientific interests are in Internal medicine, Cardiology, Atrial fibrillation, Randomized controlled trial and Surgery. His research on Internal medicine frequently links to adjacent areas such as Anesthesia. Cardiology is closely attributed to Heart rate in his work.
His research in Atrial fibrillation intersects with topics in Stroke, Electrocardiography, Severity of illness and Quality of life. He has included themes like Flecainide Acetate and Quinidine in his Randomized controlled trial study. His research integrates issues of Canadian Cardiovascular Society, Clinical trial and Intensive care medicine in his study of Heart failure.
Internal medicine, Cardiology, Atrial fibrillation, Intensive care medicine and Anesthesia are his primary areas of study. His study in Ventricular fibrillation, Heart failure, Implantable cardioverter-defibrillator, Ejection fraction and Heart disease falls under the purview of Internal medicine. His Cardiology research includes elements of Randomized controlled trial and Heart rate.
His Atrial fibrillation research includes themes of Stroke, Emergency department, Quality of life and Emergency medicine. His biological study spans a wide range of topics, including Canadian Cardiovascular Society and Clinical trial. His Anesthesia research focuses on subjects like Amiodarone, which are linked to Sotalol.
His scientific interests lie mostly in Internal medicine, Cardiology, Atrial fibrillation, Emergency medicine and Intensive care medicine. Sudden cardiac death, Heart failure, Implantable cardioverter-defibrillator, Odds ratio and Randomized controlled trial are among the areas of Internal medicine where the researcher is concentrating his efforts. His Implantable cardioverter-defibrillator study combines topics from a wide range of disciplines, such as Sudden death and Hazard ratio.
His work focuses on many connections between Cardiology and other disciplines, such as Resuscitation, that overlap with his field of interest in Ventricular fibrillation. His studies deal with areas such as Stroke, MEDLINE and Obstructive sleep apnea as well as Atrial fibrillation. His Emergency medicine research incorporates themes from Emergency department, Retrospective cohort study and Primary care physician.
Paul Dorian mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Intensive care medicine and Sudden cardiac death. His Internal medicine study focuses mostly on Heart failure, Hazard ratio, Implantable cardioverter-defibrillator, Confidence interval and Ambulatory. His Atrial fibrillation research integrates issues from Stroke, Guideline, Proportional hazards model and Angina.
The study incorporates disciplines such as Meta-analysis, Logistic regression and Heart rate in addition to Cardiology. His study in Intensive care medicine is interdisciplinary in nature, drawing from both Retrospective cohort study, Canadian Cardiovascular Society, Antithrombotic and Emergency medicine. The concepts of his Sudden cardiac death study are interwoven with issues in Incidence, Sudden death and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Stuart J. Connolly;Michael Gent;Robin S. Roberts;Paul Dorian.
Rhythm control versus rate control for atrial fibrillation and heart failure
Denis Roy;Mario Talajic;Stanley Nattel;D. George Wyse.
The New England Journal of Medicine (2008)
Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction
Stefan H. Hohnloser;Karl Heinz Kuck;Paul Dorian;Robin S. Roberts.
The New England Journal of Medicine (2004)
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Denis Roy;Mario Talajic;Paul Dorian;Stuart Connolly.
The New England Journal of Medicine (2000)
Atrial Fibrillation in Patients with Cryptogenic Stroke
David J. Gladstone;Melanie Spring;Paul Dorian;Val Panzov.
The New England Journal of Medicine (2014)
Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation
Paul Dorian;Dan Cass;Brian Schwartz;Richard Cooper.
The New England Journal of Medicine (2002)
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
Nancy Frasure-Smith;Diana Koszycki;Louis T. van Zyl;Brian Baker.
Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators: The OPTIC Study: A Randomized Trial
Stuart J. Connolly;Paul Dorian;Robin S. Roberts;Michael Gent.
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.
Paul Dorian;Werner Jung;David Newman;Miney Paquette.
Journal of the American College of Cardiology (2000)
Dronedarone in High-Risk Permanent Atrial Fibrillation
Amany N. Elgazayerly;Pieter A. de Graeff;Hubert G. Leufkens.
The New England Journal of Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: